Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | MGMT | P16455 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14562572 | 0.89 | FFAR3 (0.45) | TDP1ALDH1A1FFAR3SOAT1TSHR | |
| SCHEMBL14234014 | 0.89 | CES2 (0.46) | TDP1ALDH1A1FFAR3SOAT1CES2 | |
| SCHEMBL15315157 | 0.89 | TDP1 (0.45) | TDP1ALDH1A1FFAR3SOAT1 | |
| SCHEMBL5986397 | 0.88 | — | — | |
| SCHEMBL19510342 | 0.87 | TDP1 (0.43) | TDP1ALDH1A1FFAR3HSD17B10 | |
| SCHEMBL15867022 | 0.87 | TDP1 (0.43) | TDP1ALDH1A1FFAR3 | |
| SCHEMBL13936054 | 0.85 | — | — | |
| SCHEMBL13167778 | 0.84 | TSHR (0.42) | TDP1ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL30736083 | 0.83 | — | — | |
| SCHEMBL8379389 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1919812-A | Refining method for hexafluoromethylene aromatic compound | SHANGHAI 3F NEW MATERIAL CO LT (CN) | 2007-02-28 | — | — | CN | claimed |
| EP-0879259-B2 | PREPARATION OF DOUBLE METAL CYANIDE-CATALYZED POLYOLS BY CONTINUOUS ADDITION OF STARTER | BAYER ANTWERPEN NV (BE) | 2006-04-12 | — | — | EP | claimed |
| US-12522619-B2 | Inhibitors of complement factors and uses thereof | ANNEXON, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| EP-4463462-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | Annexon, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-118715231-A | Complement factor inhibitors and uses thereof | 安尼艾克松股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114213264-B | Beta-polyether amine, synthesis method thereof and aliphatic polyurea coating containing beta-polyether amine | 江苏朝晖化工有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20230265109-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. | 2023-08-24 | — | — | US | disclosed |
| US-20230265109-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. | 2023-08-24 | — | — | US | disclosed |
| US-20230265109-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. | 2023-08-24 | — | — | US | disclosed |
| WO-2023137166-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. (US) | 2023-07-20 | — | — | WO | disclosed |
| WO-2023137166-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. (US) | 2023-07-20 | — | — | WO | disclosed |
| CN-114213264-A | Beta-polyether amine, synthetic method thereof and aliphatic polyurea coating containing beta-polyether amine | 江苏朝晖化工有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-205115338-U | Production line by synthetic raspberry ketone of nature identical anisyl aldehyde | GUANGXI WANSHAN SPICE CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105198720-A | Production line for synthesizing raspberry ketone from natural equivalent anisic aldehyde | GUANGXI WANSHAN SPICE CO LTD | 2015-12-30 | — | — | CN | disclosed |
| CN-104541388-A | Electrochemical cells comprising electrolyte additives, and methods for making and using the same | DU PONT | 2015-04-22 | — | — | CN | disclosed |
| US-8273787-B2 | Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions | ONCONOVA THERAPEUTICS, INC (US) | 2012-09-25 | — | — | US | disclosed |
| US-20100022615-A1 | ACTIVATED CYTOTOXIC COMPOUNDS FOR ATTACHMENT TO TARGETING MOLECULES FOR THE TREATMENT OF MAMMALIAN DISEASE CONDITIONS | ONCONOVA THERAPEUTICS, INC (US) | 2010-01-28 | — | — | US | disclosed |
| EP-2058383-A1 | PENTAFLUOROBUTANE COMPOSITION | Kaneko Chemical Co., Ltd. (JP) | 2009-05-13 | — | — | EP | disclosed |
| CN-1919812-A | Refining method for hexafluoromethylene aromatic compound | SHANGHAI 3F NEW MATERIAL CO LT (CN) | 2007-02-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022615-A1 | ACTIVATED CYTOTOXIC COMPOUNDS FOR ATTACHMENT TO TARGETING MOLECULES FOR THE TREATMENT OF MAMMALIAN DISEASE CONDITIONS | CD40, TNFRSF9, NGFR | TDP1 3309/4885ALDH1A1 2628/4885FFAR3 1580/4885 |
| US-20230265109-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFB, CFH, C9 | TDP1 1413/4885ALDH1A1 653/4885FFAR3 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.